Learn More
On August 13, 2014, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals, Inc., a(More)
BACKGROUND In 2000, seven-valent pneumococcal conjugate vaccine (PCV7) was introduced in the USA and resulted in dramatic reductions in invasive pneumococcal disease (IPD) and moderate increases in(More)
OBJECTIVE To investigate the effect of performance-based financial incentives on the influenza immunization rate in primary care physicians' offices. DESIGN Randomized controlled trial during the(More)